Latest filing published 24 Mar 2024 for Gland Pharma Limited, €49k.
Filing timeline
BuySaleCh Jyothirlatha: trading record in brief
All filings by Ch Jyothirlatha on record concern Gland Pharma Limited, in the capacity of chief executive. We count 8 filings; the first trade dates from 21 May 2021 and the latest from 21 March 2024.
The open-market record consists of 7 sales worth €153k, with no purchase. Besides market trades, the filings include 1 share grant. In 2024 alone, the filings show no purchases and 1 sale.
The newest entry dates from 24 March 2024: an open-market sale of €49k, in Gland Pharma Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 3 days. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Companies and markets linked to Ch Jyothirlatha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,540 shares@ ₹1,757.120129.1% of flowEquity SharesSEBI:485dfd3db37cef5e3b9df63f7255775184f44367
- 2,000 shares@ ₹1,795.0023.4% of flowEquity SharesSEBI:368e395c66bad64fbbc70e26b015cd35f920dcda
- 2,400 shares@ ₹542.009.6% of flowEquity SharesSEBI:1d52d72abbbb76055ca17ca823a9380fa56e7fc1Canonical exit: 28 Jul 2022 (T+90)
- 1,000 shares@ ₹4,136.000.0000% mcap73.8% of flowEquity SharesSEBI:7dc83592e73cfb9ba74fb6f6f7cbeefe3381cd9e
- 200 shares@ ₹3,297.000.0000% mcap11.6% of flowEquity SharesSEBI:e0e0af25b6a97e418411d22197f4c26f6c8bb09f
- 100 shares@ ₹3,270.000.0000% mcap5.7% of flowEquity SharesSEBI:8357ba68337f062673efd990e16a11c09cf95c3f
- 100 shares@ ₹3,200.420.0000% mcap5.6% of flowEquity SharesSEBI:4ca09ed5b7812d26e68b952912d3c058ccb1982d
- 60 shares@ ₹3,209.41670.0000% mcap3.4% of flowEquity SharesSEBI:23fa0d529b32522b3431ab65ec3e8f7c4bc74c78
8 of 8 declarations